Yunnan Hongyun Health Management Services Co., Ltd. agreed to acquire additional 40% stake in Kunming Shengda Pharmaceutical Co., Ltd. from Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. (SZSE:002727) for CNY 12 million on November 20, 2015. Kunming Shengda Pharmaceutical Co., Ltd. had total assets of CNY 30.13 million, revenue of CNY 12.04 million AND operating profit of CNY 1.77 million for the year ended December 31, 2014. The deal was approved by the Board of Directors of Yunnan Hongxiang Yixintang Pharmaceutical.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.2 CNY | +1.27% | -0.31% | -17.10% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.10% | 1.58B | |
-16.93% | 18.7B | |
-29.16% | 11.29B | |
-2.30% | 6.68B | |
-1.85% | 5.5B | |
+8.03% | 5.13B | |
+34.14% | 3.9B | |
-9.09% | 3.76B | |
+3.99% | 3.51B | |
-15.22% | 3.33B |
- Stock
- Equities
- Stock Yixintang Pharmaceutical Group Co., Ltd. - Shenzhen S.E.
- News Yixintang Pharmaceutical Group Co., Ltd.
- Yunnan Hongyun Health Management Services Co., Ltd. agreed to acquire additional 40% stake in Kunming Shengda Pharmaceutical Co., Ltd. from Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. for CNY 12 million.